Business
AstraZeneca vaccine volunteer developed spinal inflammation & ‘rare neurological condition’ after two doses – report – RT
A British participant in AstraZeneca’s coronavirus vaccine trial was diagnosed with a serious neurological disorder weeks after her second dose of the inoculation, an internal company document shows.
A previously healthy 37-year-old woman was hospitalized this month after receiving two injections of the pharmaceutical giant’s new vaccine, where it was determined she developed transverse myelitis, a rare neurological ailment caused by inflammation of the spine, according to an internal AstraZeneca safety report obtained by CNN.
Though the report states the woman, who has not been identified by name, had no adverse reaction after her first dose in early June, she began to experience neurologi…
-
Business24 hours ago2 Low Cost Active ASX ETFs to consider
-
Noosa News23 hours agoQueensland government to review greenhouse gas emission reduction targets
-
Noosa News22 hours agoBrisbane news live: Broken-down train causes peak-hour delays
-
Noosa News22 hours agoSudden death investigation, Maroochydore – Sunshine Coast